Conference item icon

Conference item

Filgotinib, a Janus kinase 1 (JAK1)-selective inhibitor, modulates disease associated cytokines in patients with active rheumatoid arthritis

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2019-eular.2510

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Subgroup:
Botnar Research Centre
Oxford college:
St Peters College
ORCID:
0000-0001-7766-6167
Elboudwarej, E More by this author
Hawtin, RE More by this author
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Volume:
78
Issue:
S2
Pages:
736
Publication date:
2019-05-27
Acceptance date:
2019-03-29
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Pubs id:
pubs:987872
URN:
uri:aa6916d6-5846-4bc9-87ad-2c404e860445
UUID:
uuid:aa6916d6-5846-4bc9-87ad-2c404e860445
Local pid:
pubs:987872

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP